Skip to content
10-Q

Quarterly Report

PARDES BIOSCIENCES, INC.

0000950170-22-022581

← back to feed
Filed
Nov 7, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 1, 2022 62.32M sh
Shares Diluted Q3 2022 · Sep 30, 2022 58.38M sh
Shares Diluted Q3 2022 · Sep 30, 2022 57.72M sh
Shares Diluted Q3 2022 · Sep 30, 2021 3.06M sh
Shares Diluted Q3 2022 · Sep 30, 2021 2.06M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$59.23M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $209.06M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $268.68M
Stockholders Equity Q3 2022 · Sep 30, 2022 $202.01M
Stockholders Equity Q3 2022 · Jun 30, 2022 $222.63M
Current Liabilities Q3 2022 · Sep 30, 2022 $12.03M
Current Liabilities Q3 2022 · Dec 31, 2021 $8.97M
Total Liabilities Q3 2022 · Sep 30, 2022 $12.03M
Total Liabilities Q3 2022 · Dec 31, 2021 $8.97M
Current Assets Q3 2022 · Sep 30, 2022 $214.04M
Current Assets Q3 2022 · Dec 31, 2021 $275.26M
Total Assets Q3 2022 · Sep 30, 2022 $214.04M
Total Assets Q3 2022 · Dec 31, 2021 $275.26M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.40
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.25
Eps Diluted Q3 2022 · Sep 30, 2021 −$3.76
Eps Diluted Q3 2022 · Sep 30, 2021 −$11.73
Eps Basic Q3 2022 · Sep 30, 2022 −$0.40
Eps Basic Q3 2022 · Sep 30, 2022 −$1.25
Eps Basic Q3 2022 · Sep 30, 2021 −$3.76
Eps Basic Q3 2022 · Sep 30, 2021 −$11.73
Rd Expense Q3 2022 · Sep 30, 2022 $17.38M
Rd Expense Q3 2022 · Sep 30, 2022 $50.92M
Rd Expense Q3 2022 · Sep 30, 2021 $8.08M
Rd Expense Q3 2022 · Sep 30, 2021 $17.79M
Net Income Q3 2022 · Sep 30, 2022 −$23.34M
Net Income Q3 2022 · Sep 30, 2022 −$72.41M
Net Income Q3 2022 · Jun 30, 2022 −$27.64M
Net Income Q3 2022 · Jun 30, 2021 −$8.14M
Net Income Q3 2022 · Mar 31, 2021 −$4.52M